These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1400378)

  • 1. Casein kinase II and the tumor suppressor protein P53 associate in a molecular complex that is negatively regulated upon P53 phosphorylation.
    Filhol O; Baudier J; Delphin C; Loue-Mackenbach P; Chambaz EM; Cochet C
    J Biol Chem; 1992 Oct; 267(29):20577-83. PubMed ID: 1400378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA topoisomerase II and casein kinase II associate in a molecular complex that is catalytically active.
    Bojanowski K; Filhol O; Cochet C; Chambaz EM; Larsen AK
    J Biol Chem; 1993 Oct; 268(30):22920-6. PubMed ID: 8226802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Casein kinase 2 inhibits the renaturation of complementary DNA strands mediated by p53 protein.
    Filhol O; Baudier J; Chambaz EM; Cochet C
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):331-5. PubMed ID: 8645226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding.
    Arnold SF; Obourn JD; Jaffe H; Notides AC
    J Steroid Biochem Mol Biol; 1995 Nov; 55(2):163-72. PubMed ID: 7495695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the DNA binding of p53 by its interaction with protein kinase CK2.
    Prowald A; Schuster N; Montenarh M
    FEBS Lett; 1997 May; 408(1):99-104. PubMed ID: 9180277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53.
    Milne DM; Palmer RH; Meek DW
    Nucleic Acids Res; 1992 Nov; 20(21):5565-70. PubMed ID: 1454521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta-subunit of protein kinase CK2.
    Appel K; Wagner P; Boldyreff B; Issinger OG; Montenarh M
    Oncogene; 1995 Nov; 11(10):1971-8. PubMed ID: 7478515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of p53 mediated transactivation by the beta-subunit of protein kinase CK2.
    Schuster N; Prowald A; Schneider E; Scheidtmann KH; Montenarh M
    FEBS Lett; 1999 Mar; 447(2-3):160-6. PubMed ID: 10214938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.
    McKendrick L; Milne D; Meek D
    Mol Cell Biochem; 1999 Jan; 191(1-2):187-99. PubMed ID: 10094408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human erythrocyte casein kinase II: characterization and phosphorylation of membrane cytoskeletal proteins.
    Wei T; Tao M
    Arch Biochem Biophys; 1993 Nov; 307(1):206-16. PubMed ID: 8239658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformation-dependent phosphorylation of p53.
    Adler V; Pincus MR; Minamoto T; Fuchs SY; Bluth MJ; Brandt-Rauf PW; Friedman FK; Robinson RC; Chen JM; Wang XW; Harris CC; Ronai Z
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1686-91. PubMed ID: 9050839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
    Rolley N; Milner J
    Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.
    Meek DW; Simon S; Kikkawa U; Eckhart W
    EMBO J; 1990 Oct; 9(10):3253-60. PubMed ID: 2145148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of caldesmon by smooth-muscle casein kinase II.
    Sutherland C; Renaux BS; McKay DJ; Walsh MP
    J Muscle Res Cell Motil; 1994 Aug; 15(4):440-56. PubMed ID: 7806638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases.
    Hupp TR; Lane DP
    Cold Spring Harb Symp Quant Biol; 1994; 59():195-206. PubMed ID: 7587070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
    Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
    Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of phosphorylatable monoclonal antibody CC49 with a casein kinase II recognition site.
    Lin L; Gillies SD; Schlom J; Pestka S
    Anticancer Res; 1998; 18(6A):3971-8. PubMed ID: 9891433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modes of regulation of casein kinase II.
    Jakobi R; Lin WJ; Traugh JA
    Cell Mol Biol Res; 1994; 40(5-6):421-9. PubMed ID: 7735316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic and molecular properties of a highly purified G type casein kinase from bovine lung tissue.
    Cochet C; Feige JJ; Chambaz EM
    Biochim Biophys Acta; 1983 Feb; 743(1):1-12. PubMed ID: 6572070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
    Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
    Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.